Literature DB >> 10195779

Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages.

P De Berardinis1, L D'Apice, A Prisco, M N Ombra, P Barba, G Del Pozzo, S Petukhov, P Malik, R N Perham, J Guardiola.   

Abstract

The amino acid sequence of HIV reverse transcriptase (RT) from residue 248 to residue 262 was expressed on the surface of filamentous phage fd, fused to the major coat protein gVIIIp. The chimeric phage was used to assess the ability of anti-RT (248-262) human T cell lines and clones to become activated by the phage-displayed peptide. The RT peptide displayed on phage was recognized by the T-cells and induced production of Abs. However, not all T cells raised against the synthetic RT (248-262) peptide could respond. Lack of recognition did not depend on differences in the ability of different APCs to present the phage, but was apparently determined by the TCR specificity. The results presented here may be relevant to the design of recombinant protein-based subunit vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195779     DOI: 10.1016/s0264-410x(98)00377-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins.

Authors:  M Monette; S J Opella; J Greenwood; A E Willis; R N Perham
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

2.  Delivery strategies for novel vaccine formulations.

Authors:  Maria Trovato; Shelly J Krebs; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2012-02-12

3.  Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.

Authors:  Yanyan Huai; Shuai Dong; Ye Zhu; Xin Li; Binrui Cao; Xiang Gao; Mingying Yang; Li Wang; Chuanbin Mao
Journal:  Adv Healthc Mater       Date:  2016-02-18       Impact factor: 9.933

4.  Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.

Authors:  Nienke E van Houten; Kevin A Henry; George P Smith; Jamie K Scott
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

5.  Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.

Authors:  N E van Houten; M B Zwick; A Menendez; J K Scott
Journal:  Vaccine       Date:  2006-01-11       Impact factor: 3.641

Review 6.  Filamentous bacteriophage fd as an antigen delivery system in vaccination.

Authors:  Antonella Prisco; Piergiuseppe De Berardinis
Journal:  Int J Mol Sci       Date:  2012-04-24       Impact factor: 6.208

7.  A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda.

Authors:  Christine N Zanghi; Heather A Lankes; Birgit Bradel-Tretheway; Jessica Wegman; Stephen Dewhurst
Journal:  Nucleic Acids Res       Date:  2005-10-13       Impact factor: 16.971

8.  Targeting glioblastoma via intranasal administration of Ff bacteriophages.

Authors:  Eyal Dor-On; Beka Solomon
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

9.  Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205.

Authors:  Luciana D'Apice; Valerio Costa; Rossella Sartorius; Maria Trovato; Marianna Aprile; Piergiuseppe De Berardinis
Journal:  J Immunol Res       Date:  2015-08-26       Impact factor: 4.818

Review 10.  Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.

Authors:  Kevin A Henry; Mehdi Arbabi-Ghahroudi; Jamie K Scott
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.